Gregory Demopulos

Chief Executive Officer at OMEROS CORPORATION

Net worth: 16 M $ as of 31/05/2026

67 year

40 connections

Health Technology

Consumer Services

Miscellaneous

Profile

Gregory A. Demopulos is the founder of Omeros Corp., founded in 1994, holding the titles of Chairman, President & Chief Executive Officer since 2013.
Current jobs include Director at Onconome, Inc., Director at Tessera, Inc., Director at Northwest NeuroNeighborhood, and Trustee at Smead Funds Trust.
Education history includes undergraduate studies at Stanford University and a doctorate from Stanford University School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
OMEROS CORPORATION 2.03%	17/04/2026	14,69,308 ( 2.03% )	16 M $	31/05/2026

Gregory Demopulos active positions

Companies	Position	Start
OMEROS CORPORATION	Chief Executive Officer	16/06/1994
Tessera, Inc. Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry	Director/Board Member	-
Onconome, Inc. Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers	Director/Board Member	-
Smead Funds Trust Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust	Director/Board Member	-
Northwest NeuroNeighborhood	Director/Board Member	-

All active positions of Gregory Demopulos

Training of Gregory Demopulos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gregory Demopulos's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Omeros Corp. Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics	Health Technology
Onconome, Inc. Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers	Health Technology
Smead Funds Trust Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust	Miscellaneous
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tessera, Inc. Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry	Electronic Technology
Stanford University School of Medicine Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Northwest NeuroNeighborhood